NYSE
60,353 visningar
23 Inlägg
Rekommenderas
Senaste
🇺🇲 New York Stock Exchange Opened.
S&P500: -0.16%
Nasdaq: -0.31%
Dow Jones: +0.29%
Bitcoin - 5.85%
#Bitcoin #StockExhange #NYSE #write2earn🌐💹 #BTC $BTC $ETH $SOL
S&P500: -0.16%
Nasdaq: -0.31%
Dow Jones: +0.29%
Bitcoin - 5.85%
#Bitcoin #StockExhange #NYSE #write2earn🌐💹 #BTC $BTC $ETH $SOL
Cryptocurrency Sentiment Improves, Expecting the Market to Return😀
In Crypto, the macro sentiment continues to be improving as well. HSBC announced that they will be offering an institutional custody solution for tokenized securities in partnership with Metaco in 2024. The service will be in addition to the firm's recent efforts to hold tokenized gold, and joins JPM and Euroclear in their respective initiatives on settlement and digital security issuance.Furthermore, WSJ reported that a company run by the former NYSE President is one of the three leading parties looking to purchase and restart FTX 2.0, after vetting out supposed bidding interest from over 70 parties. With expectations for the BTC ETF approval starting to hit a crescendo, Bitcoin futures open interest on CME has hit a record high, while overall BTC future interests have also hit nearly 2 year highs across all exchanges.With DeFi coins up 70% in the past month and a bit, BTC holding its gains, and mainstream narrative continuing to thaw, are we finally back? Let's keep our fingers crossed...
#Crypto #BTC #ETF #FTX2.0 #NYSE
In Crypto, the macro sentiment continues to be improving as well. HSBC announced that they will be offering an institutional custody solution for tokenized securities in partnership with Metaco in 2024. The service will be in addition to the firm's recent efforts to hold tokenized gold, and joins JPM and Euroclear in their respective initiatives on settlement and digital security issuance.Furthermore, WSJ reported that a company run by the former NYSE President is one of the three leading parties looking to purchase and restart FTX 2.0, after vetting out supposed bidding interest from over 70 parties. With expectations for the BTC ETF approval starting to hit a crescendo, Bitcoin futures open interest on CME has hit a record high, while overall BTC future interests have also hit nearly 2 year highs across all exchanges.With DeFi coins up 70% in the past month and a bit, BTC holding its gains, and mainstream narrative continuing to thaw, are we finally back? Let's keep our fingers crossed...
#Crypto #BTC #ETF #FTX2.0 #NYSE
🚨Update: Cyberattack!! New York Stock Exchange glitch causes Warren Buffett’s Berkshire Hathaway stock to plummet 99%, other stocks affected too!
#cyberattack #NYSE
#StartInvestingInCrypto #ETHETFsApproved
#write2earn🌐💹
#cyberattack #NYSE
#StartInvestingInCrypto #ETHETFsApproved
#write2earn🌐💹
Grayscale's Strategic Move: 10,000 Bitcoin Shifts Hands in Unprecedented Transfer. 📤📨
In a recent strategic maneuver, Grayscale Bitcoin Trust (GBTC) orchestrated a substantial Bitcoin transaction, transferring 10,000 bitcoins worth $430 million to Coinbase Prime. This move, coupled with Grayscale's decision to uplist to the New York Stock Exchange (NYSE) in January 2024, marks a pivotal moment for the crypto investment giant.
The market witnessed a notable impact, experiencing a brief dip to $42,000 following the transaction, swiftly followed by a recovery to $43,000. The timing and purpose behind this influx of new bitcoin supply remain shrouded in uncertainty.
Delving into Grayscale's operations, it's revealed that their ETF paper system operates on T-1, indicating a one-day delay. Notably, the coins transferred to Coinbase Prime are still residing in the hot wallet, adding an element of anticipation to the unfolding events.
Speculations are rife regarding Grayscale's potential hedging strategy during Friday outflows, with suggestions of potential shorting activities. The spot selling observed today could be intricately connected to the closing of these speculated shorts.
The dynamics of inflows and outflows further complicate the market scenario. Friday saw a substantial influx of $700 million, only to be followed by corresponding outflows on the same day, creating a puzzling situation for market participants. Tracking these developments in real-time proves to be a challenge, given the intricate nature of Grayscale's operations.
Amidst the Bitcoin-focused narrative, the blog briefly touches upon Ethereum Mainnet developments, highlighting a subscription-based NFT offer and emphasizing timeless content promotion.
#GRAYSCALE #BTC #etf #NYSE #eth
In a recent strategic maneuver, Grayscale Bitcoin Trust (GBTC) orchestrated a substantial Bitcoin transaction, transferring 10,000 bitcoins worth $430 million to Coinbase Prime. This move, coupled with Grayscale's decision to uplist to the New York Stock Exchange (NYSE) in January 2024, marks a pivotal moment for the crypto investment giant.
The market witnessed a notable impact, experiencing a brief dip to $42,000 following the transaction, swiftly followed by a recovery to $43,000. The timing and purpose behind this influx of new bitcoin supply remain shrouded in uncertainty.
Delving into Grayscale's operations, it's revealed that their ETF paper system operates on T-1, indicating a one-day delay. Notably, the coins transferred to Coinbase Prime are still residing in the hot wallet, adding an element of anticipation to the unfolding events.
Speculations are rife regarding Grayscale's potential hedging strategy during Friday outflows, with suggestions of potential shorting activities. The spot selling observed today could be intricately connected to the closing of these speculated shorts.
The dynamics of inflows and outflows further complicate the market scenario. Friday saw a substantial influx of $700 million, only to be followed by corresponding outflows on the same day, creating a puzzling situation for market participants. Tracking these developments in real-time proves to be a challenge, given the intricate nature of Grayscale's operations.
Amidst the Bitcoin-focused narrative, the blog briefly touches upon Ethereum Mainnet developments, highlighting a subscription-based NFT offer and emphasizing timeless content promotion.
#GRAYSCALE #BTC #etf #NYSE #eth
Pfizer Stock Experiences Steep 44% Annual Drop in Value.
In a recent announcement on Friday afternoon, Pfizer (NYSE: PFE), the world's largest pharmaceutical company, revealed the discontinuation of a two-day obesity drug trial, leading to a sharp decline in its shares by over 6%. The drug, named danuglipron, faced termination due to reported side effects observed in a previous study, causing Pfizer's stocks to plummet by 44.2% since the beginning of the year.
Pfizer Abandons Obesity Drug Trial Amidst Adverse Effects:
The decision by Pfizer to forego the Phase 3 trials of its obesity drugs, formulated for twice-daily administration, stemmed from the numerous adverse effects experienced by participants in an earlier study. The company cited the drug, danuglipron, and its discontinued trial due to the side effects emerging from a Phase 2b study, indicating statistically significant weight loss compared to a placebo.
"Danuglipron demonstrated weight reductions ranging from -8% to -13% over 32 weeks and -5% to -9.5% over 26 weeks compared to placebo," stated Pfizer in a press release.
Market Response: Pfizer Stocks Experience Sharp Decline:
As the news broke, Pfizer's shares experienced a rapid decline, reaching $28.58 and marking a nearly 45% loss since the beginning of the year. This downturn is attributed to a swift decrease in sales, driven by a decline in demand for Pfizer's COVID-19 products amid the global post-pandemic recovery. The company reported losses in Q3 due to challenges surrounding its COVID-19 vaccine and antiviral treatment, Paxlovid.
Ongoing Trends in Obesity Drugs: Novo Nordisk and Eli Lilly Lead the Way:
While Pfizer faces setbacks, the market for obesity and diabetes treatments continues to evolve, with Novo Nordisk and Eli Lilly at the forefront. Novo Nordisk's Wegovy, Eli Lilly's Ozempic, and Mounjaro have set a trend with injectable medications that mimic the effects of a gut hormone to regulate appetite and blood sugar.
Novo Nordisk's Success with Wegovy and Ozempic: Novo Nordisk's Wegovy and Ozempic have been key drivers of the company's growth, with their shares rising by 48% and 64.31%, respectively. These GLP-1 receptor agonists have gained approval in the United States for the treatment of type 2 diabetes, showcasing their effectiveness in managing both diabetes and obesity.Eli Lilly's Mounjaro and Zepbound, and the FDA Approval for Weight Management: Eli Lilly's Mounjaro, similar to Novo Nordisk's Ozempic, and Zepbound, akin to Mounjaro, have received approval from the U.S. Food and Drug Administration (FDA) not only for the treatment of type 2 diabetes but also for weight management. This dual approval positions these medications as versatile solutions for patients struggling with both conditions.
While Pfizer grapples with the discontinuation of its obesity drug trial, competitors Novo Nordisk and Eli Lilly continue to thrive in the evolving landscape of obesity and diabetes treatments. The industry's focus on innovative solutions reflects a commitment to addressing the complex challenges of these prevalent health conditions, providing hope for improved outcomes for patients in the future.
#Pfizer #NYSE #PFE #COVID-19
Pfizer Abandons Obesity Drug Trial Amidst Adverse Effects:
The decision by Pfizer to forego the Phase 3 trials of its obesity drugs, formulated for twice-daily administration, stemmed from the numerous adverse effects experienced by participants in an earlier study. The company cited the drug, danuglipron, and its discontinued trial due to the side effects emerging from a Phase 2b study, indicating statistically significant weight loss compared to a placebo.
"Danuglipron demonstrated weight reductions ranging from -8% to -13% over 32 weeks and -5% to -9.5% over 26 weeks compared to placebo," stated Pfizer in a press release.
Market Response: Pfizer Stocks Experience Sharp Decline:
As the news broke, Pfizer's shares experienced a rapid decline, reaching $28.58 and marking a nearly 45% loss since the beginning of the year. This downturn is attributed to a swift decrease in sales, driven by a decline in demand for Pfizer's COVID-19 products amid the global post-pandemic recovery. The company reported losses in Q3 due to challenges surrounding its COVID-19 vaccine and antiviral treatment, Paxlovid.
Ongoing Trends in Obesity Drugs: Novo Nordisk and Eli Lilly Lead the Way:
While Pfizer faces setbacks, the market for obesity and diabetes treatments continues to evolve, with Novo Nordisk and Eli Lilly at the forefront. Novo Nordisk's Wegovy, Eli Lilly's Ozempic, and Mounjaro have set a trend with injectable medications that mimic the effects of a gut hormone to regulate appetite and blood sugar.
Novo Nordisk's Success with Wegovy and Ozempic: Novo Nordisk's Wegovy and Ozempic have been key drivers of the company's growth, with their shares rising by 48% and 64.31%, respectively. These GLP-1 receptor agonists have gained approval in the United States for the treatment of type 2 diabetes, showcasing their effectiveness in managing both diabetes and obesity.Eli Lilly's Mounjaro and Zepbound, and the FDA Approval for Weight Management: Eli Lilly's Mounjaro, similar to Novo Nordisk's Ozempic, and Zepbound, akin to Mounjaro, have received approval from the U.S. Food and Drug Administration (FDA) not only for the treatment of type 2 diabetes but also for weight management. This dual approval positions these medications as versatile solutions for patients struggling with both conditions.
While Pfizer grapples with the discontinuation of its obesity drug trial, competitors Novo Nordisk and Eli Lilly continue to thrive in the evolving landscape of obesity and diabetes treatments. The industry's focus on innovative solutions reflects a commitment to addressing the complex challenges of these prevalent health conditions, providing hope for improved outcomes for patients in the future.
#Pfizer #NYSE #PFE #COVID-19
ChatGPT-4o predicts Bitcoin’s price Potential NYSE listing
The New York Stock Exchange (NYSE) is considering implementing cryptocurrency trading, although the current regulatory framework prevents moving forward. Such an outcome would naturally have a positively impact on the demand for Bitcoin (BTC).
The AI model predicts a significant surge in price due to short-term speculation about a potential NYSE listing, estimating a 20% to 30% increase in price.
Looking ahead, OpenAI's main product is projected to be priced at $100,000 to $120,000 in the near future, factoring in factors like new investors, enhanced credibility, and wider acceptance over the next six to 12 months.
In the long run, the AI model anticipates Bitcoin's price to fall within the range of $150,000 to $200,000, making it the leading cryptocurrency in terms of value.
#Megadrop #BTC☀ #btcupdates2024 #BTC100Ksoon #NYSE
The New York Stock Exchange (NYSE) is considering implementing cryptocurrency trading, although the current regulatory framework prevents moving forward. Such an outcome would naturally have a positively impact on the demand for Bitcoin (BTC).
The AI model predicts a significant surge in price due to short-term speculation about a potential NYSE listing, estimating a 20% to 30% increase in price.
Looking ahead, OpenAI's main product is projected to be priced at $100,000 to $120,000 in the near future, factoring in factors like new investors, enhanced credibility, and wider acceptance over the next six to 12 months.
In the long run, the AI model anticipates Bitcoin's price to fall within the range of $150,000 to $200,000, making it the leading cryptocurrency in terms of value.
#Megadrop #BTC☀ #btcupdates2024 #BTC100Ksoon #NYSE
Technical failure at the NYSE
👀 An unexpected technical failure occurred on the #NYSE , which led to a sharp drop in the shares of some companies. In particular, shares of Berkshire Hathaway fell by 99.9%. 📉 This was due to a malfunction in the application processing system, which led to the incorrect determination of share prices.
🤷 Trading was temporarily suspended for some #stocks while the #exchange investigated the cause of the outage. Experts believe that this may be due to changes in the software or insufficient scalability of the system.
And they say crypto trading is unreliable... 🤔
#BnbAth #StartInvestingInCrypto
👀 An unexpected technical failure occurred on the #NYSE , which led to a sharp drop in the shares of some companies. In particular, shares of Berkshire Hathaway fell by 99.9%. 📉 This was due to a malfunction in the application processing system, which led to the incorrect determination of share prices.
🤷 Trading was temporarily suspended for some #stocks while the #exchange investigated the cause of the outage. Experts believe that this may be due to changes in the software or insufficient scalability of the system.
And they say crypto trading is unreliable... 🤔
#BnbAth #StartInvestingInCrypto
NYSE Glitch Underscores Need for Decentralized Oracles – Is Chainlink the Answer?
Today's NYSE trading halt, triggered by a technical glitch, sent shockwaves through the market. While the issue was resolved, it's a stark reminder of the vulnerabilities inherent in centralized systems. Could decentralized oracle networks like Chainlink be the solution to prevent future disruptions?
Chainlink, a blockchain-based network, provides tamper-proof and reliable data feeds to smart contracts. By leveraging decentralized nodes, it eliminates single points of failure, ensuring data integrity and accuracy. This could be crucial for stock exchanges, where real-time, accurate price data is paramount.
Key Advantages of Chainlink for Stock Exchanges:
‣ Decentralization: Eliminates single points of failure, reducing the risk of market disruptions.
‣ Data Integrity: Provides tamper-proof price feeds, ensuring accurate and reliable data.
‣ Real-Time Updates: Delivers real-time data to prevent trading halts due to outdated information.
Questions for the Community:
‣ Could Chainlink integration prevent similar glitches in the future?
‣ How would decentralized oracles impact traditional financial markets?
‣ Is the stock market ready for blockchain-based solutions?
Let's discuss!
$LINK
#ChainlinkUpdate #LINK🔥🔥🔥 #NYSE #DeFi
Today's NYSE trading halt, triggered by a technical glitch, sent shockwaves through the market. While the issue was resolved, it's a stark reminder of the vulnerabilities inherent in centralized systems. Could decentralized oracle networks like Chainlink be the solution to prevent future disruptions?
Chainlink, a blockchain-based network, provides tamper-proof and reliable data feeds to smart contracts. By leveraging decentralized nodes, it eliminates single points of failure, ensuring data integrity and accuracy. This could be crucial for stock exchanges, where real-time, accurate price data is paramount.
Key Advantages of Chainlink for Stock Exchanges:
‣ Decentralization: Eliminates single points of failure, reducing the risk of market disruptions.
‣ Data Integrity: Provides tamper-proof price feeds, ensuring accurate and reliable data.
‣ Real-Time Updates: Delivers real-time data to prevent trading halts due to outdated information.
Questions for the Community:
‣ Could Chainlink integration prevent similar glitches in the future?
‣ How would decentralized oracles impact traditional financial markets?
‣ Is the stock market ready for blockchain-based solutions?
Let's discuss!
$LINK
#ChainlinkUpdate #LINK🔥🔥🔥 #NYSE #DeFi
Is #NYSE copying #Crypto?
The New York Stock Exchange is contemplating a plan for round-the-clock trading
This could be a big change for institutional investors
#investments #trading
The New York Stock Exchange is contemplating a plan for round-the-clock trading
This could be a big change for institutional investors
#investments #trading
#Cryptocurrency markets operate continuously, trading every day of the week, around the clock. In a similar vein, reports indicate that the New York Stock Exchange (#NYSE ) is exploring the possibility of shifting to 24/7 operations. 💪
The data team at NYSE has conducted a survey among its investors, revealing a strong interest in the availability of 24x7 Trading.🔥
The data team at NYSE has conducted a survey among its investors, revealing a strong interest in the availability of 24x7 Trading.🔥
💫 New York Stock Exchange Partners with Coindesk Indices
The New York Stock Exchange (NYSE) is collaborating with Coindesk Indices to launch financial products equivalent to spot Bitcoin prices. This partnership aims to bridge traditional finance with the burgeoning cryptocurrency market, providing investors with new and innovative ways to engage with Bitcoin.
#NYSE #Coindesk #Bitcoin $BTC
The New York Stock Exchange (NYSE) is collaborating with Coindesk Indices to launch financial products equivalent to spot Bitcoin prices. This partnership aims to bridge traditional finance with the burgeoning cryptocurrency market, providing investors with new and innovative ways to engage with Bitcoin.
#NYSE #Coindesk #Bitcoin $BTC
Lynn Martin, chairman of the board of directors of NYSE Group, the parent company of the New York Stock Exchange:
We have had discussions with the SEC about Bitcoin for over 6 years. You can't argue with the success of Bitcoin ETFs and the liquidity they bring to the markets in which they are traded.
#NYSE #btc $BTC
We have had discussions with the SEC about Bitcoin for over 6 years. You can't argue with the success of Bitcoin ETFs and the liquidity they bring to the markets in which they are traded.
#NYSE #btc $BTC
Hold on to your hats, #BerkshireHathaway drama!
The stock is supposedly down 99% but #NYSE says it's a glitch.
Investigation in Progress.
#WarrenBuffett #StockMarket #DowJones
The stock is supposedly down 99% but #NYSE says it's a glitch.
Investigation in Progress.
#WarrenBuffett #StockMarket #DowJones
🚨 BlackRock and Citadel Plan to Open a New National Exchange in Texas to Compete with NYSE
In a bold move to shake up the financial markets, BlackRock and Citadel have announced plans to open a new national stock exchange in Texas. This new exchange aims to provide a competitive alternative to the New York Stock Exchange (NYSE), leveraging Texas' favorable business climate and innovative financial infrastructure.
#BlackRock #Citadel #NYSE #btc $BTC
In a bold move to shake up the financial markets, BlackRock and Citadel have announced plans to open a new national stock exchange in Texas. This new exchange aims to provide a competitive alternative to the New York Stock Exchange (NYSE), leveraging Texas' favorable business climate and innovative financial infrastructure.
#BlackRock #Citadel #NYSE #btc $BTC
